Literature DB >> 29553306

Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA.

Kumar Mukherjee1, Khalid M Kamal2.   

Abstract

BACKGROUND: Atrial fibrillation is a significant risk factor for ischemic stroke and increases cost of treatment. AIMS: To estimate the incremental inpatient cost and length of stay due to atrial fibrillation among adults hospitalized with a primary diagnosis of ischemic stroke after controlling for sociodemographic, clinical, and hospital characteristics in a nationally representative discharge record of US population.
METHODS: Hospital discharge records with a primary diagnosis of ischemic stroke were identified from the National Inpatient Sample data for the years 2010-2013. Generalized linear model with log link and least-square means were utilized to estimate the incremental inpatient cost and length of stay in ischemic stroke due to atrial fibrillation after controlling for sociodemographic, clinical, and hospital characteristics.
RESULTS: Among 434,544 hospital discharge records with a primary diagnosis of ischemic stroke, 90,190 (20.76%) discharge records had a secondary diagnosis of atrial fibrillation. The average inpatient cost for all discharge records with a primary diagnosis of ischemic stroke was (mean = $13,072, median = $9270.87) significantly (p < 0.0001) higher compared to all discharge records without ischemic stroke (mean = $12,543.07, median = $7517.13). The mean length of stay for all records was 4.55 days (95% CI = 4.53-4.56). Among those identified with ischemic stroke, adjusted mean inpatient cost was higher by $2829 (95% CI = $2708-$2949) and mean length of stay was greater by 0.85 (95% CI = 0.81-0.89) for those with atrial fibrillation compared to those without.
CONCLUSIONS: The presence of atrial fibrillation was associated with increased inpatient cost and length of stay among patients diagnosed with ischemic stroke. Increased inpatient cost and length of stay call for a more comprehensive patient care approach including targeted interventions among adults diagnosed with ischemic stroke and atrial fibrillation, which could potentially reduce the overall cost in this population.

Entities:  

Keywords:  Ischemic stroke; atrial fibrillation; burden of atrial fibrillation; economics; hospital characteristics; inpatient cost; length of stay; outcomes research

Mesh:

Year:  2018        PMID: 29553306     DOI: 10.1177/1747493018765491

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

1.  Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.

Authors:  Chisa Matsumoto; Hisao Ogawa; Yoshihiko Saito; Sadanori Okada; Hirofumi Soejima; Mio Sakuma; Izuru Masuda; Masafumi Nakayama; Naofumi Doi; Hideaki Jinnouchi; Masako Waki; Takeshi Morimoto
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

2.  Embolic Cerebrovascular Accident Secondary to Device-Related Thrombus Post WATCHMAN Device Implantation.

Authors:  Palak Patel; Nagapratap Ganta; Giuseppe Filice; Ivan Richard; Frederick Acquah; Dina Alnabwani; Harshil B Patel
Journal:  Cureus       Date:  2022-07-15

3.  Mid-term outcomes of concomitant Cox-Maze IV: Results from a multicenter prospective registry.

Authors:  Marc Gerdisch; Eric Lehr; Gansevoort Dunnington; John Johnkoski; Andrew Barksdale; Manesh Parikshak; Patrick Ryan; Samuel Youssef; Robert Fletcher; Glenn Barnhart
Journal:  J Card Surg       Date:  2022-07-23       Impact factor: 1.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.